These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Drug checking as a potential strategic overdose response in the fentanyl era. Laing MK; Tupper KW; Fairbairn N Int J Drug Policy; 2018 Dec; 62():59-66. PubMed ID: 30359874 [TBL] [Abstract][Full Text] [Related]
4. Reframing the Prevention Strategies of the Opioid Crisis: Focusing on Prescription Opioids, Fentanyl, and Heroin Epidemic. Manchikanti L; Sanapati J; Benyamin RM; Atluri S; Kaye AD; Hirsch JA Pain Physician; 2018 Jul; 21(4):309-326. PubMed ID: 30045589 [TBL] [Abstract][Full Text] [Related]
5. A survey of North American drug checking services operating in 2022. Park JN; Tardif J; Thompson E; Rosen JG; Lira JAS; Green TC Int J Drug Policy; 2023 Nov; 121():104206. PubMed ID: 37797571 [TBL] [Abstract][Full Text] [Related]
6. Point-of-Care Drug of Abuse Testing in the Opioid Epidemic. Li Z; Wang P Arch Pathol Lab Med; 2020 Nov; 144(11):1325-1334. PubMed ID: 32579399 [TBL] [Abstract][Full Text] [Related]
7. Physician Perspective and Challenges Ordering/Interpreting Laboratory Tests Related to the Opioid Crisis in America. Zhu X; Bratanow NC Ther Drug Monit; 2021 Feb; 43(1):6-13. PubMed ID: 33230042 [TBL] [Abstract][Full Text] [Related]
8. Urine and oral fluid drug testing in support of pain management. Kwong TC; Magnani B; Moore C Crit Rev Clin Lab Sci; 2017 Sep; 54(6):433-445. PubMed ID: 28990451 [TBL] [Abstract][Full Text] [Related]
9. Opioid prescription patterns in Germany and the global opioid epidemic: Systematic review of available evidence. Rosner B; Neicun J; Yang JC; Roman-Urrestarazu A PLoS One; 2019; 14(8):e0221153. PubMed ID: 31461466 [TBL] [Abstract][Full Text] [Related]
10. The Opioid Epidemic: Challenge to Military Medicine and National Security. Dembek ZF; Chekol T; Wu A Mil Med; 2020 Jun; 185(5-6):e662-e667. PubMed ID: 32077961 [TBL] [Abstract][Full Text] [Related]
12. Drug checking services as a surveillance tool for clinical laboratories: Examining trends in the unregulated fentanyl supply. Delaney SR; Konforte D; Stefan C; Palaty J; Sun D; McDonald K; Thompson H; Werb D; Beriault DR Clin Biochem; 2023 Jan; 111():11-16. PubMed ID: 36379241 [TBL] [Abstract][Full Text] [Related]
13. Laboratory testing for prescription opioids. Milone MC J Med Toxicol; 2012 Dec; 8(4):408-16. PubMed ID: 23180358 [TBL] [Abstract][Full Text] [Related]
14. The North American Opioid Epidemic. Jannetto PJ Ther Drug Monit; 2021 Feb; 43(1):1-5. PubMed ID: 33337587 [TBL] [Abstract][Full Text] [Related]
15. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia. Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144 [TBL] [Abstract][Full Text] [Related]
16. Development of an UPLC-MS/MS method for the analysis of 16 synthetic opioids in segmented hair, and evaluation of the polydrug history in fentanyl analogue users. RamÃrez Fernández MDM; Wille SMR; Jankowski D; Hill V; Samyn N Forensic Sci Int; 2020 Feb; 307():110137. PubMed ID: 31927248 [TBL] [Abstract][Full Text] [Related]
17. The Opioid Epidemic Within the COVID-19 Pandemic: Drug Testing in 2020. Niles JK; Gudin J; Radcliff J; Kaufman HW Popul Health Manag; 2021 Feb; 24(S1):S43-S51. PubMed ID: 33031013 [TBL] [Abstract][Full Text] [Related]
18. Measuring What Matters: How the Laboratory Contributes Value in the Opioid Crisis. Warrington JS; Swanson K; Dodd M; Lo SY; Haghamad A; Duque TB; Cook B J Appl Lab Med; 2020 Nov; 5(6):1378-1390. PubMed ID: 33147341 [TBL] [Abstract][Full Text] [Related]
19. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS). Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473 [TBL] [Abstract][Full Text] [Related]
20. New Psychoactive Substances and receding COVID-19 pandemic: really going back to "normal"? Napoletano S; Basile G; Lo Faro AF; Negro F Acta Biomed; 2022 May; 93(2):e2022186. PubMed ID: 35545997 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]